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Abstract 
Objective: To evaluate the relationship between 
Loop Electrosurgical Excision Procedure (LEEP) 
margin status and subsequent cytology results 
to determine the significance of margin status as 
a predictor for recurrent cervical disease.  
Methods: A retrospective cohort of women who 
underwent LEEP for treatment of cervical 
dysplasia from 1995 to 2006 with subsequent 
follow-up to 2009 at a single academic 
institution. Data extracted consisted of 
information routinely collected during clinic visits 
including demographic information, LEEP 
histology results, and cytology results.  
Results: The analysis was limited to 144 women 
with documented LEEP margin status and 
subsequent cytologic follow-up. The women 
were predominantly white, non-Hispanic, with a 
mean age of 27 years (range 14 – 62 years). Of 
the 144 LEEP specimens, 77 had negative 
margins, and 67 had positive margins (44 ecto-
cervical, 16 endo-cervical, 7 both ecto-cervical 
and endo-cervical margins involved). Twenty-
three women required subsequent colposcopy 
during the follow-up period: 7 with negative 
margin status and 16 with positive margin status 
on their initial LEEP. There was no association 
between LEEP margin status, grade of 
dysplasia, or depth of excision, and subsequent 
abnormal cytology (P>0.05 for each). There was 
no association between positive ecto-cervical or 
endo-cervical margin status and subsequent 
abnormal cytology (P>0.05 for each).  
Conclusion: We were unable to identify factors 
related to LEEP margin status to predict 
recurrent abnormal cytology. Thus, we 
recommend surveillance of all women following 
LEEP for cervical dysplasia regardless of margin 
status. 
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Background 
Over the past two decades, data has 
emerged regarding the natural history of 
cervical intraepithelial neoplasia (CIN) in 
various age groups. Concomitant 
evidence showing obstetrical risk 
following treatment for CIN has led to 
the re-evaluation of guidelines for the 
management of abnormal cervical 
cancer screening tests and 
premalignant cervical disease with a 
trend towards conservative 
management.1 However, surgical 
therapies remain the mainstay of 
treatment for high grade cervical 
intraepithelial neoplasia (CIN 2,3). Loop 
electrosurgical excision procedure 
(LEEP) is a commonly utilized 
diagnostic and treatment modality for 
CIN 2,3 because it provides a specimen 
for histological examination while being 
safe and effective in the outpatient 
setting.2 In select patients, it also has 
the advantage of allowing diagnosis and 
treatment in a single visit.2 Treatment is 
not without risk, however. As stated 
above, increased obstetrical risks 
following treatment with LEEP include 
preterm premature rupture of 
membranes, preterm delivery, and low 
birth weight.3-5 Such risks highlight the 
trend for more conservative 
management of CIN 2 and CIN 2,3 
especially in younger populations.  
Women who have undergone treatment 
for CIN 2,3 are also at risk for persistent 
or recurrent disease, with rates of 
disease persistence/recurrence ranging 
from 2-48% following LEEP.4,6-8 Such 
women are also at increased risk for 
developing invasive cervical cancer for 
as many as 20 years following 
treatment, further highlighting the need 
for follow-up in these patients.9 Various 
follow-up schedules have been 
proposed, but data regarding the most 
effective follow-up schedule for 
detecting disease persistence or 
recurrence is lacking. It is also unclear 
whether women with incomplete 
excision by LEEP, as evidenced by the 
histologic presence of CIN at the margin 
of the excised specimen, are at an 
increased risk of disease persistence or 
recurrence.  For such women, the most 
recent consensus guidelines from the 
American Society for Colposcopy and 
Cervical Pathology (ASCCP) 
preferentially recommend follow-up with 
cytology and endocervical sampling 
over re-excision; however, repeat 
excision is acceptable.1 Nonetheless, 
uncertainty remains as to whether 
immediate re-excision or close clinical 
follow-up is the best course of action. 
This study seeks to add to the growing 
body of literature regarding the 
significance of positive margin status 
following LEEP as it relates to the 
patient’s risk for future abnormal cervical 
cytology. 
Methods 
This represents a retrospective cohort 
study of women who underwent LEEP 
for cervical dysplasia at a single 
academic institution from 1995 to 2006 
with follow-up to 2009. The protocol for 
the study was approved by the 
Institutional Review Board.  All women 
who underwent a LEEP procedure for 
cervical dysplasia with known margin 
status and who had subsequent 
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cytological follow up were eligible for 
analysis.  
Data extracted consisted of information 
routinely collected during clinic visits 
including demographic information, 
cytology results, and LEEP histology 
results. LEEP specimen margin status 
was analyzed with regards to residual 
disease (positive, negative), margin 
involved (ectocervical, endocervical), 
and grade of dysplasia present at the 
margin. The grade of dysplasia at the 
margin was stratified as normal (normal, 
inflammation, CIN 1) or abnormal (CIN 
2, CIN 3, adenocarcinoma in-situ, micro-
invasive cancer, invasive cancer). Pap 
smear results of atypical squamous cells 
(ASC) and low grade intraepithelial 
lesions (LSIL) were classified as mild; 
atypical squamous cells, cannot exclude 
high grade (ASC-H), high grade 
intraepithelial lesions (HSIL), and 
atypical glandular cells (AGC) were 
classified as severe. For patients with 
multiple post-LEEP cytology results, the 
most abnormal result was used in the 
analysis. 
Data was analyzed by univariate 
analysis using Fisher’s exact test to 
determine whether LEEP specimen 
margin status was correlated with 
subsequent cytology results. For 
continuous variables, Wilcoxon rank 
sum test was applied to examine the 
correlation between depth of excision 
and subsequent cervical cytology.  
For variables with ample data, 
multivariate analysis with logistic 
regression using stepwise selection was 
used. Because of limited sample size, 
for multivariate analysis, subsequent 
Pap smear results were re-categorized 
with non-clinically significant disease 
classified as normal (ASC, LSIL) and 
clinically significant disease classified as 
abnormal (ASC-H, HSIL, AGC). 
Covariates included age, current 
smoking status, gravidity, parity, 
contraceptive use, history of 
gynecologic disease, and result of the 
most recent colposcopy prior to the 
treatment of interest. 
Results 
Two hundred and twenty-eight women 
were identified who underwent LEEP for 
treatment of high grade cervical 
dysplasia at our institution from 1995 to 
2006. Follow-up cytology was available 
for 167 of the women. The analysis was 
limited to 144 women for whom both 
documented LEEP margin status and 
cytological follow-up data were 
available.  
The women were predominantly white, 
non-Hispanic, with a mean age of 27 
years (range 14-62).  Demographics for 
the women who underwent LEEP are 
presented (Table 1).   
Similar to other reviews, current 
smoking status was associated with 
referral for treatment of cervical 
dysplasia (LEEP) (p=0.04).  Use of 
hormonal birth control (primarily 
combined oral contraceptives) 
approached significance for referral for 
treatment (p=0.06). Demographic 
variables were not associated with 
follow-up cytology results on univariate 
or multivariate analyses.  
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Table 1. Demographics of all LEEP 
patients (n=228) 
Age (years) p-value 
Range 14-62 ns 
Mean 27  
OB history Number (%) ns 
Nulligravida 61 (27)  
Previous pregnancy 162 (71)  
Missing information 5 (2)  
Smoking status Number (%)  0.04 
Non-smoker 113 (50)  
Current smoker 109 (48)  
Missing information 6 (2)  
Birth control Number (%)  0.06 
Yes 137 (60)  
No 90 (39)  
Missing information 1 (0)  
ns=not significant 
 
The LEEP pathology reported positive 
margin status in 67 (47%) of the 
specimens and negative margin status 
in 77 (53%). For those specimens with a 
positive margin status where the 
involved margin was specified, the 
ectocervical margin was positive in 51 
specimens and the endocervical margin 
was positive in 23 (this includes 7 
specimens in which both the ecto- and 
endo-cervical margins were involved).  
The frequency of subsequent Pap 
smear results by margin status is 
presented in Table 2.  
 
Table 2. Frequency of subsequent Pap smear results by margin status (n=144)  
  Follow-up Pap smear result p-value 
  Normal Mild Severe 
LEEP margin status 
    Positive 33 24 10 
0.56 
Negative 40 30 7 
Endocervical margin 
   
 
Positive 8 10 5 
0.13 
Negative 24 13 5 
Ectocervical margin 
   
 
Positive 27 18 6 
0.25 
Negative 5 5 4 
Margin Grade 
   
 
Normal/Low(≤CIN I) 19 9 4 
0.30 
Moderate/High (≥CIN II) 13 15 5 
Margin Depth 
    Mean (mm) 11.12 10.78 9.73 0.15 
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In those with a positive LEEP margin, 
post-LEEP cytology results were normal 
in 33 women, mild in 24, and severe in 
10. In those with a negative LEEP 
margin, post-LEEP cytology results 
were normal in 40, mild in 30, and 
severe in 7. There was no correlation 
between follow-up cytology result and 
positive or negative margin status 
(p=0.56). Likewise there was no 
correlation between follow-up cytology 
result and margin involved (endo- or 
ecto-cervical) (p =0.13) or grade of 
dysplasia identified at the margin (p 
=0.30) 
The mean depth of excision was 11.12 
mm in those with normal cytology post-
LEEP, 10.78 mm in those with a mild 
result, and 9.73 mm in those with a 
severe result. Using Wilcoxon rank sum 
test, there was no significant difference 
noted between mean depth of excision 
and follow-up cytology result (p =0.15).  
Twenty-three women required 
subsequent colposcopy during the 
follow-up period: 7 with negative margin 
status and 16 with a positive margin 
status on their initial LEEP. The result of 
the follow-up colposcopy was not found 
to be significantly different based upon 
initial margin status (p=0.19), grade of 
dysplasia at the margin (p=0.33), or 
depth of excision (p=0.82). Additionally, 
multivariate analysis using the 
covariates listed above found no 
significant factors. However, when the 
sample was restricted to women who 
had a positive margin at initial treatment, 
the margin depth approached 
significance (p=0.06). 
Discussion 
The present study sought to evaluate 
the significance of a positive margin 
following treatment with LEEP as it 
relates to risk for future abnormal 
cytology. Although guidelines for the 
management of such patients exist, 
there is little data or consensus on 
whether these patients should be 
followed clinically or undergo re-
excision. Furthermore, no data exists 
regarding adherence to the present 
recommendations following treatment. 
In an attempt to determine the best 
course of action for such patients, many 
studies, including this one, have looked 
at risk factors for recurrence of cervical 
dysplasia to determine those patients for 
whom the risk of disease recurrence 
outweighs the risks of re-excision. While 
re-excision in patients with a positive 
margin is well tolerated and effective,6,10 
there are risks associated with re-
excision. Risks of repeat excision must 
be weighed against the potential risk of 
untreated CIN or the potential for a 
missed diagnosis of invasive carcinoma 
within an un-excised focus at the 
involved margin. This has become 
especially important in light of recent 
data showing increased obstetrical risks 
following LEEP and the desire to 
therefore limit cervical excision in 
women desiring future fertility.3-5 
In the present study, we were unable to 
identify risk factors to predict recurrent 
abnormal cytology related to LEEP 
margin status. Previous studies have 
reported conflicting results, with many 
studies showing a statistically higher 
rate of disease recurrence (as 
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determined by follow-up cytology) in 
those with a positive LEEP resection 
margin.8,11-17 Margin status was 
compared in several studies, again with 
conflicting results: statistically higher 
rate of persistence/recurrence was seen 
only in those patients with involvement 
of the ectocervical margin17 or 
endocervical margin7,12,16 or only with 
extensive involvement of the margin.13 
Limitations of our study include the 
small sample size. This is largely a 
reflection of the referral population base 
and study methods. The majority of 
women who are referred to the 
University for evaluation of abnormal 
cervical cytology and treatment of 
cervical dysplasia are cared for by 
practitioners from a wide geographical 
area and tend to receive follow up care 
with their referring providers  Thus, we 
do not have available post-LEEP 
cytology for all women. Another 
limitation was the transition of our clinic 
records from a paper record to an 
electronic medical record during the 
study period. Thus, some women who 
underwent LEEP did not have all the 
required information and were excluded. 
While our findings are limited, it is 
unlikely that our findings have been 
biased by the referral population or 
methods available. Our findings are 
similar to other studies in that non-
invasive LEEP histology is a poor 
predictor of recurrent CIN following 
LEEP. 
In conclusion, we were unable to identify 
which women are at risk for a 
recurrence of CIN following LEEP based 
on margin status. Thus, we recommend 
surveillance of all women who have 
undergone LEEP for treatment of CIN 
regardless of margin status. 
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